These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3691964)

  • 1. History of the acceptance of human diploid cell strains as substrates for human virus vaccine manufacture.
    Hayflick L; Plotkin S; Stevenson RE
    Dev Biol Stand; 1987; 68():9-17. PubMed ID: 3691964
    [No Abstract]   [Full Text] [Related]  

  • 2. A perfusion culture system for virus vaccine manufacture in diploid cell cultures.
    Mann GF; de Mucha Macías J
    Bull Pan Am Health Organ; 1976; 10(3):205-11. PubMed ID: 187274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A consideration of the cell substrates used in human virus vaccine preparation.
    Hayflick L
    Prog Immunobiol Stand; 1967; 3():86-93. PubMed ID: 4314442
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivity of a referent human diploid cell strain WI-38 to different viruses. II].
    Trlifajová J; Strízová V; Hejdová E
    Cesk Epidemiol Mikrobiol Imunol; 1970 Jan; 19(1):27-44. PubMed ID: 4313215
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of cell cultures in vaccine production: diploid and stable cell cultures.
    Matchett A
    J Am Vet Med Assoc; 1970 Jun; 156(12):1791-4. PubMed ID: 4987214
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of diploid cell lines as a multiplication substrate for viral vaccine production].
    Welke G
    Z Gesamte Hyg; 1980; 26(5):365-72. PubMed ID: 7008390
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.
    Tatalick LM; Gerard CJ; Takeya R; Price DN; Thorne BA; Wyatt LM; Anklesaria P
    Vaccine; 2005 Apr; 23(20):2628-38. PubMed ID: 15780446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cell-containing substrates and vaccine production].
    Majer M
    Schweiz Med Wochenschr; 1970 Nov; 100(48):2086-9. PubMed ID: 5003834
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 4 adenovirus vaccine, live, prepared in human diploid cell system for oral administration.
    Tint H; Stone JL; Minecci LC; Rubin BA
    Prog Immunobiol Stand; 1967; 3():113-22. PubMed ID: 5379935
    [No Abstract]   [Full Text] [Related]  

  • 11. Human diploid cell strains (HDCS) viral vaccines.
    Fletcher MA; Hessel L; Plotkin SA
    Dev Biol Stand; 1998; 93():97-107. PubMed ID: 9737384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The large-scale cultivation of diploid cell strains in microcarrier culture. Improvement of microcarriers.
    van Wezel AL
    Dev Biol Stand; 1976 Dec 13-15; 37():143-7. PubMed ID: 1031679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology of production of primary and diploid cell cultures.
    Brackett RG
    Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonhuman primate diploid cells for vaccine production.
    Petricciani JC
    Dev Biol Stand; 1976 Dec 13-15; 37():21-5. PubMed ID: 1036399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic requirements of viral vaccines and methods for their control].
    Osidse DF
    Arch Exp Veterinarmed; 1980; 34(1):123-6. PubMed ID: 6774690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Karyologic characteristics of the WI-38 diploid cell system--general comments.
    Rubin BA; Minecci LC; Tint H
    Natl Cancer Inst Monogr; 1968 Dec; 29():97-104. PubMed ID: 5720816
    [No Abstract]   [Full Text] [Related]  

  • 17. Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines.
    Yerganian G; Nell MA; Cho SS; Hayford AH; Ho T
    Natl Cancer Inst Monogr; 1968 Dec; 29():241-68. PubMed ID: 4306757
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral oncogenicity and viral vaccines--general comments.
    Gerber P
    Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
    [No Abstract]   [Full Text] [Related]  

  • 19. Suggested criteria for the acceptability of a passaged diploid cell population as substrate for virus vaccine production.
    Perkins FT
    Jpn J Med Sci Biol; 1971 Oct; 24(5):336-41. PubMed ID: 5003825
    [No Abstract]   [Full Text] [Related]  

  • 20. Reappraisal of karyological monitoring of diploid cell substrates.
    Moorhead PS
    Dev Biol Stand; 1976 Dec 13-15; 37():157-61. PubMed ID: 1031682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.